NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHLBI E-048-2009-0-US-04 Tensioning Device and Methods for Use US DIV 14/956,238 10285813 Issued PDF
NCI E-162-2009-0-US-10 Pharmaceutical Compositions Which Inhibit FKBP52-Mediated Regulation Of Androgen Receptor Function and Methods of Using Same US CON 14/955,505 9782399 Abandoned PDF
NCI E-285-2006-2-US-08 Differential Gene Expression In Physiological and Pathological Angiogenesis US DIV 14/954,509 Abandoned
NIBIB E-314-2013-0-IE-09 Octapod Iron Oxide Nanoparticles As High-Performance T2 Contrast Agents For Magnetic Resonance Imaging IE EP 13886302.2 Abandoned
NIBIB E-314-2013-0-DE-06 Octapod Iron Oxide Nanoparticles As High-Performance T2 Contrast Agents For Magnetic Resonance Imaging DE EP 13886302.2 Abandoned
NIBIB E-314-2013-0-FR-07 Octapod Iron Oxide Nanoparticles As High-Performance T2 Contrast Agents For Magnetic Resonance Imaging FR EP 13886302.2 Abandoned
NIBIB E-314-2013-0-GB-08 Octapod Iron Oxide Nanoparticles As High-Performance T2 Contrast Agents For Magnetic Resonance Imaging GB EP 13886302.2 Abandoned
NIBIB E-314-2013-0-CH-05 Octapod Iron Oxide Nanoparticles As High-Performance T2 Contrast Agents For Magnetic Resonance Imaging CH EP 13886302.2 Abandoned
NIA E-101-2010-0-US-04 Regulatory B Cells (tBregs) And Their Uses US CON 14/952,768 9657269 Issued PDF
NHLBI E-175-2012-0-HK-07 Method of Preparing Silca-Coated Nanodiamonds HK National Stage 15111586.0 Abandoned
NCATS E-004-2016-0-US-01 Substituted Bicyclic Heteroaryl Inhibitors Of Bromodomain-containing Protein BRD4 US 62/259,894 Abandoned
NCI E-028-2015-1-SG-12 Anti-Mutated Kras T Cell Receptors SG National Stage 11201704155U Issued
NCI E-028-2015-1-CN-04 Anti-Mutated Kras T Cell Receptors CN National Stage 201580070673.7 Issued
NCI E-028-2015-1-MX-09 Anti-Mutated Kras T Cell Receptors MX National Stage MX/a/2017/006865 Issued
NCI E-028-2015-1-JP-07 Anti-Mutated Kras T Cell Receptors JP National Stage 2017-527874 Issued
NCI E-028-2015-1-SA-11 Anti-Mutated Kras T Cell Receptors SA National Stage 517381608 Issued
NCI E-028-2015-1-AU-02 Anti-Mutated Kras T Cell Receptors AU National Stage 2015353720 Issued
NCI E-028-2015-1-AT-17 Anti-Mutated Kras T Cell Receptors AT EP 15807756.0 Issued
NCI E-028-2015-1-BE-18 Anti-Mutated Kras T Cell Receptors BE EP 15807756.0 Issued
NCI E-028-2015-1-IT-27 Anti-Mutated Kras T Cell Receptors IT EP 15807756.0 Issued
NCI E-028-2015-1-CZ-20 Anti-Mutated Kras T Cell Receptors CZ EP 15807756.0 Issued
NCI E-028-2015-1-IE-26 Anti-Mutated Kras T Cell Receptors IE EP 15807756.0 Issued
NCI E-028-2015-1-GR-25 Anti-Mutated Kras T Cell Receptors GR EP 15807756.0 Issued
NCI E-028-2015-1-PL-30 Anti-Mutated Kras T Cell Receptors PL EP 15807756.0 Issued
NCI E-028-2015-1-SI-33 Anti-Mutated Kras T Cell Receptors SI EP 15807756.0 Issued
NCI E-028-2015-1-NL-28 Anti-Mutated Kras T Cell Receptors NL EP 15807756.0 Issued
NCI E-028-2015-1-PT-31 Anti-Mutated Kras T Cell Receptors PT EP 15807756.0 Issued
NCI E-028-2015-1-NO-29 Anti-Mutated Kras T Cell Receptors NO EP 15807756.0 Issued
NCI E-028-2015-1-SK-34 Anti-Mutated Kras T Cell Receptors SK EP 15807756.0 Issued
NCI E-028-2015-1-SE-32 Anti-Mutated Kras T Cell Receptors SE EP 15807756.0 Issued
NCI E-028-2015-1-CH-19 Anti-Mutated Kras T Cell Receptors CH EP 15807756.0 Issued
NCI E-028-2015-1-TR-35 Anti-Mutated Kras T Cell Receptors TR EP 15807756.0 Issued
NCI E-028-2015-1-ES-22 Anti-Mutated Kras T Cell Receptors ES EP 15807756.0 Issued
NCI E-028-2015-1-FR-23 Anti-Mutated Kras T Cell Receptors FR EP 15807756.0 Issued
NCI E-028-2015-1-DE-21 Anti-Mutated Kras T Cell Receptors DE EP 15807756.0 Issued
NCI E-028-2015-1-EP-05 Anti-Mutated Kras T Cell Receptors EP National Stage 15807756.0 Issued
NCI E-028-2015-1-GB-24 Anti-Mutated Kras T Cell Receptors GB EP 15807756.0 Issued
NICHD E-008-2015-0-PCT-02 Joint Probability Distribution Determinations for Material Assessments PCT PCT PCT/US2015/062489 Expired
NCATS E-214-2014-1-PCT-01 Small Molecule Aldehyde Dehydrogenase Inhibitors And Methods Of Use Thereof PCT PCT COMB PCT/US2015/062467 Expired
NCI E-028-2015-1-PCT-01 Anti-Mutated Kras T Cell Receptors PCT PCT COMB PCT/US2015/062269 Expired
NCI E-213-2014-0-EP-01 Methodology For Astatination And Radioiodination Based On Iodonium Salt Precursors EP ORD 15306862.2 Abandoned
NIAID E-067-2016-1-US-01 A Novel Method Of Vaccination With An Attenuated RSV Vaccine Formulation US 62/259,472 Abandoned
NCI E-028-2015-1-CA-03 Anti-Mutated Kras T Cell Receptors CA National Stage 2968399 Pending
NINR E-349-2013-2-US-02 Detection and Treatment of Irritable Bowel Syndrome US National Stage 14/892,999 9683263 Issued PDF
NCI E-010-2016-1-US-01 Anti-BCMA Polypeptides and Proteins US 62/257,493 Abandoned
NIAID E-045-2015-0-EP-06 Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use EP DIV 21158309.1 Abandoned
NIAID E-045-2015-0-EP-03 Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use EP National Stage 15797815.6 Issued
NIAID E-045-2015-0-GB-09 Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use GB EP 15797815.6 Issued
NIAID E-045-2015-0-FR-08 Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use FR EP 15797815.6 Issued
NIAID E-045-2015-0-IT-10 Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use IT EP 15797815.6 Issued